Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: promise and concern

J AAPOS. 2009 Aug;13(4):329-31. doi: 10.1016/j.jaapos.2009.06.003.
No abstract available

Publication types

  • Comment
  • Editorial
  • Introductory Journal Article

MeSH terms

  • Adolescent
  • Angiogenesis Inhibitors / administration & dosage*
  • Angiogenesis Inhibitors / adverse effects
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Child
  • Child, Preschool
  • Humans
  • Infant
  • Ranibizumab
  • Retinal Diseases / drug therapy*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Ranibizumab